Janus Henderson Group’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.31M | Buy |
+472,392
| New | +$6.31M | ﹤0.01% | 834 |
|
|
2025
Q1 | – | Sell |
-14,307
| Closed | -$226K | – | 2512 |
|
|
2024
Q4 | $226K | Sell |
14,307
-77,803
| -84% | -$1.23M | ﹤0.01% | 2380 |
|
|
2024
Q3 | $5.35M | Buy |
92,110
+77,803
| +544% | +$4.52M | ﹤0.01% | 863 |
|
|
2024
Q2 | $654K | Buy |
14,307
+4,475
| +46% | +$204K | ﹤0.01% | 1855 |
|
|
2024
Q1 | $649K | Buy |
9,832
+15
| +0.2% | +$990 | ﹤0.01% | 1873 |
|
|
2023
Q4 | $391K | Sell |
9,817
-15
| -0.2% | -$597 | ﹤0.01% | 2105 |
|
|
2023
Q3 | $313K | Buy |
9,832
+3
| +0% | +$96 | ﹤0.01% | 2162 |
|
|
2023
Q2 | $395K | Hold |
9,829
| – | – | ﹤0.01% | 2110 |
|
|
2023
Q1 | $420K | Buy |
+9,829
| New | +$420K | ﹤0.01% | 2120 |
|